Epidermal Growth Factor Receptor (EGFR) Inhibitors Screened from Autodisplayed Fv-Antibody Library
Bioconjugate Chemistry · 2024
DOI: 10.1021/acs.bioconjchem.4c00256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2024. Verfasst von Jeong Soo Sung und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Science and Engineering, Yonsei University, 50 Yonsei-Ro, Seodaemun-Gu, Seoul 03722, Republic of Korea. Hauptthemen laut MEDLINE: ErbB Receptors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, National Research Foundation of Korea.
Abstract (Originalsprache)
Inhibitors of the epithermal growth factor receptor (EGFR) were screened from an autodisplayed Fv-antibody library using an anti-EGF antibody. The Fv-antibody library was expressed on the outer membrane of Escherichia coli, which corresponds to the heavy chain VH region of immunoglobulin G. The library was constructed by randomizing the CDR3 region of expressed VH regions (11 amino acid residues) by site-directed mutagenesis. Using an anti-EGF antibody as a screening probe, amino acid sequences (CDR3 region) with antibody binding affinity were screened from the Fv-antibody library. These amino acid sequences were considered to have similar chemical properties to EGF, which can bind to EGFR. Two autodisplayed clones with Fv-antibodies against EGFR were screened from the Fv-antibody library, and the screened Fv-antibodies were expressed as soluble proteins. The binding affinity (KD) was estimated using an SPR biosensor, and the inhibitory activity of expressed Fv-antibodies was observed for PANC-1 pancreatic tumor cells and T98G glioblastoma cells using Western blot analysis of proteins in the EGFR-mediated signaling pathway. The viability of PANC-1 and T98G cells was observed to decrease via the inhibitory activity of expressed Fv-antibodies. Finally, interactions between Fv-antibodies and EGFR were analyzed by using molecular docking simulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Materials Science and Engineering, Yonsei University, 50 Yonsei-Ro, Seodaemun-Gu, Seoul 03722, Republic of Korea.
- Korea Institute of Science and Technology (KIST), Seoul 02792, Korea.
- Institute of Pharmaceutical and Medical Chemistry, Universität Münster, Münster 48149, Germany.
- Division of Life Sciences, College of Life Science and Bioengineering, Incheon National University, Incheon 22012, Korea.
- Institute for New Drug Development, College of Life Science and Bioengineering, Incheon National University, Incheon 22012, South Korea.
ORCID-Profile: Hyung Eun Bae, Joachim Jose, Jae-Chul Pyun
Förderung
- Korea Health Industry Development Institute
- National Research Foundation of Korea
Zitieren
APA
Sung, J. S., Jung, J., Kim, T. H., Kwon, S., Bae, H. E., Kang, M. J., Jose, J., Lee, M., & Pyun, J. C. (2024). Epidermal Growth Factor Receptor (EGFR) Inhibitors Screened from Autodisplayed Fv-Antibody Library. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.4c00256
Vancouver
Sung JS, Jung J, Kim TH, Kwon S, Bae HE, Kang MJ, et al. Epidermal Growth Factor Receptor (EGFR) Inhibitors Screened from Autodisplayed Fv-Antibody Library. Bioconjugate Chemistry. 2024. doi:10.1021/acs.bioconjchem.4c00256
BibTeX
@article{Sung2024,
author = {Sung, Jeong Soo and Jung, Jaeyong and Kim, Tae-Hun and Kwon, Soonil and Bae, Hyung Eun and Kang, Min-Jung and Jose, Joachim and Lee, Misu and Pyun, Jae-Chul},
title = {Epidermal Growth Factor Receptor (EGFR) Inhibitors Screened from Autodisplayed Fv-Antibody Library},
journal = {Bioconjugate Chemistry},
year = {2024},
doi = {10.1021/acs.bioconjchem.4c00256}
}
EUVIMED